Click here to get full coverage on Hims & Hers Scales Technology-Enabled, Vertically Integrated Care - Yahoo Finance

Hims & Hers Scales Technology-Enabled, Vertically Integrated Care  Yahoo Finance

Hims & Hers Scales Technology-Enabled, Vertically Integrated Care - Yahoo Finance

Click here to get full coverage on Hims & Hers: Fast-Fashion Healthcare Is The Future (Rating Upgrade) (NYSE:HIMS) - Seeking Alpha

Hims & Hers: Fast-Fashion Healthcare Is The Future (Rating Upgrade) (NYSE:HIMS)  Seeking Alpha

Hims & Hers: Fast-Fashion Healthcare Is The Future (Rating Upgrade) (NYSE:HIMS) - Seeking Alpha

Click here to get full coverage on How Trump’s GLP-1 move may affect telehealth companies’ fortunes - Modern Healthcare News

How Trump’s GLP-1 move may affect telehealth companies’ fortunes  Modern Healthcare News

How Trump’s GLP-1 move may affect telehealth companies’ fortunes - Modern Healthcare News

Click here to get full coverage on Healthcare Technology Stocks Q3 Teardown: Hims & Hers Health (NYSE:HIMS) Vs The Rest - Yahoo Finance

Healthcare Technology Stocks Q3 Teardown: Hims & Hers Health (NYSE:HIMS) Vs The Rest  Yahoo Finance

Healthcare Technology Stocks Q3 Teardown: Hims & Hers Health (NYSE:HIMS) Vs The Rest - Yahoo Finance

Click here to get full coverage on Options Corner: Hims & Hers Health's Downturn Presents A Compelling Opportunity For Quants - Benzinga

Options Corner: Hims & Hers Health's Downturn Presents A Compelling Opportunity For Quants  Benzinga

Options Corner: Hims & Hers Health's Downturn Presents A Compelling Opportunity For Quants - Benzinga

Click here to get full coverage on Why Hims & Hers Health (HIMS) Is Down 7.6% After Narrowing 2025 Revenue Guidance and Q3 Results - Yahoo Finance

Why Hims & Hers Health (HIMS) Is Down 7.6% After Narrowing 2025 Revenue Guidance and Q3 Results  Yahoo Finance

Why Hims & Hers Health (HIMS) Is Down 7.6% After Narrowing 2025 Revenue Guidance and Q3 Results - Yahoo Finance

Click here to get full coverage on Is Hims & Hers Health Worth a Look After 23.9% Pullback in 2025? - Yahoo Finance

Is Hims & Hers Health Worth a Look After 23.9% Pullback in 2025?  Yahoo Finance

Is Hims & Hers Health Worth a Look After 23.9% Pullback in 2025? - Yahoo Finance

Click here to get full coverage on Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Clorox and more - CNBC

Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Clorox and more  CNBC

Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Clorox and more - CNBC

Click here to get full coverage on Hims and Hers tops revenue estimates as telehealth provider attracts more users - Reuters

Hims and Hers tops revenue estimates as telehealth provider attracts more users  Reuters

Hims and Hers tops revenue estimates as telehealth provider attracts more users - Reuters

Click here to get full coverage on Hims & Hers: GLP-1 Partnership Could Unlock Value (NYSE:HIMS) - Seeking Alpha

Hims & Hers: GLP-1 Partnership Could Unlock Value (NYSE:HIMS)  Seeking Alpha

Hims & Hers: GLP-1 Partnership Could Unlock Value (NYSE:HIMS) - Seeking Alpha

Click here to get full coverage on A Fresh Look at Hims & Hers Health (HIMS) Valuation Following Strong Q3 Growth and Expansion Moves - simplywall.st

A Fresh Look at Hims & Hers Health (HIMS) Valuation Following Strong Q3 Growth and Expansion Moves  simplywall.st

A Fresh Look at Hims & Hers Health (HIMS) Valuation Following Strong Q3 Growth and Expansion Moves - simplywall.st

Click here to get full coverage on Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results - Hims Investor Relations

Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results  Hims Investor Relations

Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results - Hims Investor Relations

Click here to get full coverage on Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus

Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS)  GuruFocus

Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus

Click here to get full coverage on Hims & Hers Scales Technology-Enabled, Vertically Integrated Care - Zacks Investment Research

Hims & Hers Scales Technology-Enabled, Vertically Integrated Care  Zacks Investment Research

Hims & Hers Scales Technology-Enabled, Vertically Integrated Care - Zacks Investment Research

Click here to get full coverage on Hims & Hers Health Third-Quarter Revenue Jumps as Subscribers Grow - WSJ - The Wall Street Journal

Hims & Hers Health Third-Quarter Revenue Jumps as Subscribers Grow - WSJ  The Wall Street Journal

Hims & Hers Health Third-Quarter Revenue Jumps as Subscribers Grow - WSJ - The Wall Street Journal

Click here to get full coverage on Hims & Hers in talks with Novo Nordisk to sell Wegovy injections, new obesity pill - Fierce Healthcare

Hims & Hers in talks with Novo Nordisk to sell Wegovy injections, new obesity pill  Fierce Healthcare

Hims & Hers in talks with Novo Nordisk to sell Wegovy injections, new obesity pill - Fierce Healthcare

Click here to get full coverage on Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock? - The Motley Fool

Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock?  The Motley Fool

Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock? - The Motley Fool

Click here to get full coverage on 2 Strong Healthcare Stock Picks for Growth Investors - The Globe and Mail

2 Strong Healthcare Stock Picks for Growth Investors  The Globe and Mail

2 Strong Healthcare Stock Picks for Growth Investors - The Globe and Mail

Click here to get full coverage on How we’re reaching more customers with a new standard of care - Hims & Hers Newsroom

How we’re reaching more customers with a new standard of care  Hims & Hers Newsroom

How we’re reaching more customers with a new standard of care - Hims & Hers Newsroom

Click here to get full coverage on Hims & Hers Health’s Q3 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Hims & Hers Health’s Q3 Earnings Call: Our Top 5 Analyst Questions  Yahoo Finance

Hims & Hers Health’s Q3 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Click here to get full coverage on Hims Shares Rise on Talks to Offer Novo’s New Obesity Pill - Yahoo Finance

Hims Shares Rise on Talks to Offer Novo’s New Obesity Pill  Yahoo Finance

Hims Shares Rise on Talks to Offer Novo’s New Obesity Pill - Yahoo Finance

Click here to get full coverage on Hims & Hers Health (HIMS): Exploring Valuation as Q3 Earnings and GLP-1 Launch Boost Market Activity - Yahoo Finance

Hims & Hers Health (HIMS): Exploring Valuation as Q3 Earnings and GLP-1 Launch Boost Market Activity  Yahoo Finance

Hims & Hers Health (HIMS): Exploring Valuation as Q3 Earnings and GLP-1 Launch Boost Market Activity - Yahoo Finance

Click here to get full coverage on Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care - Yahoo Finance

Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care  Yahoo Finance

Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care - Yahoo Finance

Click here to get full coverage on 2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors - The Globe and Mail

2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors  The Globe and Mail

2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors - The Globe and Mail

Click here to get full coverage on Is Hims & Hers Health Still a Smart Opportunity After 124% Stock Surge in 2025? - Yahoo Finance

Is Hims & Hers Health Still a Smart Opportunity After 124% Stock Surge in 2025?  Yahoo Finance

Is Hims & Hers Health Still a Smart Opportunity After 124% Stock Surge in 2025? - Yahoo Finance

Click here to get full coverage on Hims Reverses Lower Despite Potential Deal With Novo - Investor's Business Daily

Hims Reverses Lower Despite Potential Deal With Novo  Investor's Business Daily

Hims Reverses Lower Despite Potential Deal With Novo - Investor's Business Daily

Click here to get full coverage on Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? - Yahoo Finance

Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?  Yahoo Finance

Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? - Yahoo Finance

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Click here to get full coverage on Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Expansion Plans - Quiver Quantitative

Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Expansion Plans  Quiver Quantitative

Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Expansion Plans - Quiver Quantitative

Click here to get full coverage on Why Hims & Hers Health (HIMS) Faces New Questions on Pricing Power After Third-Quarter GLP-1 Updates - simplywall.st

Why Hims & Hers Health (HIMS) Faces New Questions on Pricing Power After Third-Quarter GLP-1 Updates  simplywall.st

Why Hims & Hers Health (HIMS) Faces New Questions on Pricing Power After Third-Quarter GLP-1 Updates - simplywall.st

Click here to get full coverage on Earnings call transcript: Hims & Hers Health Q3 2025 misses EPS, stock rebounds - Investing.com

Earnings call transcript: Hims & Hers Health Q3 2025 misses EPS, stock rebounds  Investing.com

Earnings call transcript: Hims & Hers Health Q3 2025 misses EPS, stock rebounds - Investing.com

Click here to get full coverage on Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? - Yahoo Finance

Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?  Yahoo Finance

Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? - Yahoo Finance

Click here to get full coverage on Hims & Hers Co-Founder Launches At-Home Acne Injection Brand - The Business of Fashion

Hims & Hers Co-Founder Launches At-Home Acne Injection Brand  The Business of Fashion

Hims & Hers Co-Founder Launches At-Home Acne Injection Brand - The Business of Fashion

Click here to get full coverage on HIMS Stock Declines Despite Launch of New Specialty in Women's Health - Yahoo Finance

HIMS Stock Declines Despite Launch of New Specialty in Women's Health  Yahoo Finance

HIMS Stock Declines Despite Launch of New Specialty in Women's Health - Yahoo Finance

Click here to get full coverage on Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025 - Hims Investor Relations

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025  Hims Investor Relations

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025 - Hims Investor Relations

Click here to get full coverage on Hims & Hers Stock Nosedives -- CEO Cashes Out $11 Million Stake - Yahoo Finance

Hims & Hers Stock Nosedives -- CEO Cashes Out $11 Million Stake  Yahoo Finance

Hims & Hers Stock Nosedives -- CEO Cashes Out $11 Million Stake - Yahoo Finance

Click here to get full coverage on Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Launch - Quiver Quantitative

Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Launch  Quiver Quantitative

Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Launch - Quiver Quantitative

Click here to get full coverage on Hims & Hers Health Inc (HIMS) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance

Hims & Hers Health Inc (HIMS) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and ...  Yahoo Finance

Hims & Hers Health Inc (HIMS) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Yahoo Finance

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory  Yahoo Finance

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Hims & Hers Eyes Major Weight-Loss Breakthrough With Potential Novo Nordisk Wegovy Deal - Yahoo Finance

Hims & Hers Eyes Major Weight-Loss Breakthrough With Potential Novo Nordisk Wegovy Deal  Yahoo Finance

Hims & Hers Eyes Major Weight-Loss Breakthrough With Potential Novo Nordisk Wegovy Deal - Yahoo Finance

Click here to get full coverage on Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results - Hims Investor Relations

Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results  Hims Investor Relations

Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results - Hims Investor Relations

Click here to get full coverage on Can Hims & Hers Keep Its GLP-1 Edge After Trump Forces Lilly And Novo To Slash Prices? Wall Street Isn’t Convinced - Stocktwits

Can Hims & Hers Keep Its GLP-1 Edge After Trump Forces Lilly And Novo To Slash Prices? Wall Street Isn’t Convinced  Stocktwits

Can Hims & Hers Keep Its GLP-1 Edge After Trump Forces Lilly And Novo To Slash Prices? Wall Street Isn’t Convinced - Stocktwits

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) Q3 Earnings Match Estimates - Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Q3 Earnings Match Estimates  Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Q3 Earnings Match Estimates - Yahoo Finance

Click here to get full coverage on Boughton, Hims & Hers health CLO, sells $112k in shares - Investing.com India

Boughton, Hims & Hers health CLO, sells $112k in shares  Investing.com India

Boughton, Hims & Hers health CLO, sells $112k in shares - Investing.com India

Click here to get full coverage on Hims to begin selling GLP-1 microdosing treatments - Sherwood News

Hims to begin selling GLP-1 microdosing treatments  Sherwood News

Hims to begin selling GLP-1 microdosing treatments - Sherwood News

Click here to get full coverage on Hims & Hers Health’s (NYSE:HIMS) Q3 Sales Top Estimates - Yahoo Finance

Hims & Hers Health’s (NYSE:HIMS) Q3 Sales Top Estimates  Yahoo Finance

Hims & Hers Health’s (NYSE:HIMS) Q3 Sales Top Estimates - Yahoo Finance

Click here to get full coverage on Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - Yahoo Finance

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today  Yahoo Finance

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - Yahoo Finance

Click here to get full coverage on Hims & Hers Health (HIMS) Margin Compression Challenges Bullish Narratives Despite Sustained Profit Growth - Yahoo Finance

Hims & Hers Health (HIMS) Margin Compression Challenges Bullish Narratives Despite Sustained Profit Growth  Yahoo Finance

Hims & Hers Health (HIMS) Margin Compression Challenges Bullish Narratives Despite Sustained Profit Growth - Yahoo Finance

Click here to get full coverage on Hims & Hers Shares Plunge as Amazon Enters Telehealth Arena - AD HOC NEWS

Hims & Hers Shares Plunge as Amazon Enters Telehealth Arena  AD HOC NEWS

Hims & Hers Shares Plunge as Amazon Enters Telehealth Arena - AD HOC NEWS

Click here to get full coverage on Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026 - Hims Investor Relations

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026  Hims Investor Relations

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026 - Hims Investor Relations

Click here to get full coverage on Hims & Hers: Use This Drop Before It's Too Late (NYSE:HIMS) - Seeking Alpha

Hims & Hers: Use This Drop Before It's Too Late (NYSE:HIMS)  Seeking Alpha

Hims & Hers: Use This Drop Before It's Too Late (NYSE:HIMS) - Seeking Alpha

Click here to get full coverage on U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims - Reuters

U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims  Reuters

U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims - Reuters

Click here to get full coverage on Hims & Hers to Offer Treatments for Menopause, Perimenopause - The Wall Street Journal

Hims & Hers to Offer Treatments for Menopause, Perimenopause  The Wall Street Journal

Hims & Hers to Offer Treatments for Menopause, Perimenopause - The Wall Street Journal

Click here to get full coverage on Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser - The New York Times

Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser  The New York Times

Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser - The New York Times

Click here to get full coverage on Hims & Hers gains as analysts welcome talks with Novo for Wegovy sales - Seeking Alpha

Hims & Hers gains as analysts welcome talks with Novo for Wegovy sales  Seeking Alpha

Hims & Hers gains as analysts welcome talks with Novo for Wegovy sales - Seeking Alpha

Click here to get full coverage on Hims & Hers launches treatment plans for low testosterone - Reuters

Hims & Hers launches treatment plans for low testosterone  Reuters

Hims & Hers launches treatment plans for low testosterone - Reuters

Click here to get full coverage on Hims & Hers Health (HIMS): How the Menopause Launch Shapes Valuation and Growth Expectations - Yahoo Finance

Hims & Hers Health (HIMS): How the Menopause Launch Shapes Valuation and Growth Expectations  Yahoo Finance

Hims & Hers Health (HIMS): How the Menopause Launch Shapes Valuation and Growth Expectations - Yahoo Finance

Click here to get full coverage on Hims & Hers Health down 11% after CEO Dudum stock sale disclosure - Seeking Alpha

Hims & Hers Health down 11% after CEO Dudum stock sale disclosure  Seeking Alpha

Hims & Hers Health down 11% after CEO Dudum stock sale disclosure - Seeking Alpha

Click here to get full coverage on The New Standard in Testosterone Treatment: Exclusive Branded Oral Testosterone and Expanded Treatment Options - Hims & Hers Newsroom

The New Standard in Testosterone Treatment: Exclusive Branded Oral Testosterone and Expanded Treatment Options  Hims & Hers Newsroom

The New Standard in Testosterone Treatment: Exclusive Branded Oral Testosterone and Expanded Treatment Options - Hims & Hers Newsroom

Click here to get full coverage on Hims & Hers Short Interest Nears All-Time High, Buy The Dip? - MarketBeat

Hims & Hers Short Interest Nears All-Time High, Buy The Dip?  MarketBeat

Hims & Hers Short Interest Nears All-Time High, Buy The Dip? - MarketBeat

Click here to get full coverage on HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? - Zacks Investment Research

HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now?  Zacks Investment Research

HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? - Zacks Investment Research

Click here to get full coverage on Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why - Yahoo Finance

Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why  Yahoo Finance

Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why - Yahoo Finance

Click here to get full coverage on Hims & Hers: There's Opportunity In This Crash (Upgrade) - Seeking Alpha

Hims & Hers: There's Opportunity In This Crash (Upgrade)  Seeking Alpha

Hims & Hers: There's Opportunity In This Crash (Upgrade) - Seeking Alpha

Click here to get full coverage on Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025 - Hims Investor Relations

Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025  Hims Investor Relations

Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025 - Hims Investor Relations

Click here to get full coverage on Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance

Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q2 Earnings?  Yahoo Finance

Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance

Click here to get full coverage on Hims & Hers Stock Jumps 9% After Huge Announcement - Nasdaq

Hims & Hers Stock Jumps 9% After Huge Announcement  Nasdaq

Hims & Hers Stock Jumps 9% After Huge Announcement - Nasdaq

Click here to get full coverage on Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled - Investor's Business Daily

Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled  Investor's Business Daily

HIMS

Price Chart

Key Statistics

Technicals

About HIMS

Latest News

Hims & Hers Scales Technology-Enabled, Vertically Integrated Care - Yahoo Finance

Hims & Hers: Fast-Fashion Healthcare Is The Future (Rating Upgrade) (NYSE:HIMS) - Seeking Alpha

How Trump’s GLP-1 move may affect telehealth companies’ fortunes - Modern Healthcare News

Advanced Charts

Top Gainers

Top Losers